Application 077317
- Type
- ANDA
- Sponsor
- WATSON LABS TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ISRADIPINE | ISRADIPINE | CAPSULE;ORAL | 2.5MG | No | No |
| 002 | ISRADIPINE | ISRADIPINE | CAPSULE;ORAL | 5MG | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16252-539 | Isradipine | Isradipine | Actavis Pharma, Inc. | ANDA | Current |
| 16252-539 | Isradipine | Isradipine | Actavis Pharma, Inc. | ANDA | Current |
| 16252-540 | Isradipine | Isradipine | Actavis Pharma, Inc. | ANDA | Current |
| 16252-540 | Isradipine | Isradipine | Actavis Pharma, Inc. | ANDA | Current |
| 50268-454 | Isradipine | Isradipine | AvPAK | ANDA | Current |
| 50268-454 | Isradipine | Isradipine | AvPAK | ANDA | Current |
| 50268-455 | Isradipine | Isradipine | AvPAK | ANDA | Current |
| 50268-455 | Isradipine | Isradipine | AvPAK | ANDA | Current |
| 50268-455 | Isradipine | Isradipine | AvPAK | ANDA | Current |
| 68151-1333 | Isradipine | Isradipine | Carilion Materials Management | ANDA | Current |